BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16906584)

  • 81. Quantitative detection of zeta-chain-associated protein 70 expression in chronic lymphocytic leukemia.
    Zhu P; Degheidy HA; Marti GE; Li S; Abbasi F; Wiestner A; Amstutz P; Tang CM
    Leuk Lymphoma; 2013 Mar; 54(3):579-86. PubMed ID: 22839722
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Prognostic markers of CLL--"watch and wait" and transplantation].
    Cetkovský P
    Vnitr Lek; 2006 Dec; 52(12):1148-9. PubMed ID: 17299906
    [No Abstract]   [Full Text] [Related]  

  • 83. Differential expression and function of CD27 in chronic lymphocytic leukemia cells expressing ZAP-70.
    Lafarge ST; Hou S; Pauls SD; Johnston JB; Gibson SB; Marshall AJ
    Leuk Res; 2015 Jul; 39(7):773-8. PubMed ID: 26002513
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Prognostic significance of new biological markers in chronic lymphocytic leukaemia].
    Leković D; Mihaljević B; Kraguljac-Kurtović N; Perunčić-Jovanović M; Bogdanović A; Čolović M; Gotić M
    Srp Arh Celok Lek; 2011; 139(11-12):753-8. PubMed ID: 22338471
    [TBL] [Abstract][Full Text] [Related]  

  • 85. T-cell ZAP-70 overexpression in chronic lymphocytic leukemia (CLL) correlates with CLL cell ZAP-70 levels, clinical stage and disease progression.
    Herishanu Y; Kay S; Rogowski O; Pick M; Naparstek E; Deutsch VR; Polliack A
    Leukemia; 2005 Jul; 19(7):1289-91. PubMed ID: 15843823
    [No Abstract]   [Full Text] [Related]  

  • 86. Correlation between ZAP-70, phospho-ZAP-70, and phospho-Syk expression in leukemic cells from patients with CLL.
    Kaplan D; Meyerson HJ; Li X; Drasny C; Liu F; Costaldi M; Barr P; Lazarus HM
    Cytometry B Clin Cytom; 2010 Mar; 78(2):115-22. PubMed ID: 20014315
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Combined analysis of ZAP-70 and CD38 expression in sudanese patients with B-cell chronic lymphocytic leukemia.
    Basabaeen AA; Abdelgader EA; BaHashwan OS; Babekir EA; Abdelateif NM; Bamusa SA; Abdelrahim SO; Altayeb OA; Fadul EA; Ibrahim IK
    BMC Res Notes; 2019 May; 12(1):282. PubMed ID: 31122288
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Using the geometric mean fluorescence intensity index method to measure ZAP-70 expression in patients with chronic lymphocytic leukemia.
    Wu YJ; Wang H; Liang JH; Miao Y; Liu L; Qiu HR; Qiao C; Wang R; Li JY
    Onco Targets Ther; 2016; 9():797-805. PubMed ID: 26937202
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A single tube 10-color flow cytometry assay optimizes detection of minimal residual disease in chronic lymphocytic leukemia.
    Sartor MM; Gottlieb DJ
    Cytometry B Clin Cytom; 2013 Mar; 84(2):96-103. PubMed ID: 23283845
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [The prognostic value of smudge cells (Gumprecht shadows) in chronic lymphocytic leukaemia].
    Szerafin L; Jakó J; Riskó F; Hevessy Z
    Orv Hetil; 2012 Nov; 153(44):1732-7. PubMed ID: 23103742
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Flow Cytometric Analysis of ZAP-70 Protein Expression for B-Cell Chronic Lymphocytic Leukemia Prognostication: Usefulness and Limitations.
    Shaikh MS; Ahmed A; Sohail S; Fahim A; Nohario SH; Pervez S
    Cureus; 2020 Nov; 12(11):e11691. PubMed ID: 33391925
    [TBL] [Abstract][Full Text] [Related]  

  • 92. CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential.
    Deaglio S; Vaisitti T; Aydin S; Bergui L; D'Arena G; Bonello L; Omedé P; Scatolini M; Jaksic O; Chiorino G; Efremov D; Malavasi F
    Blood; 2007 Dec; 110(12):4012-21. PubMed ID: 17699742
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Comparison of Bcl-2, CD38 and ZAP-70 Expression in Chronic Lymphocytic Leukemia.
    Sargent RL; Craig FE; Swerdlow SH
    Int J Clin Exp Pathol; 2009 Jun; 2(6):574-82. PubMed ID: 19636404
    [TBL] [Abstract][Full Text] [Related]  

  • 94. ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia.
    Chen L; Huynh L; Apgar J; Tang L; Rassenti L; Weiss A; Kipps TJ
    Blood; 2008 Mar; 111(5):2685-92. PubMed ID: 18048647
    [TBL] [Abstract][Full Text] [Related]  

  • 95. B-CLL cells from lymph nodes express higher ZAP-70 levels than B-CLL cells from peripheral blood.
    Boelens J; Philippé J; Offner F
    Leuk Res; 2007 May; 31(5):719-20. PubMed ID: 16890284
    [No Abstract]   [Full Text] [Related]  

  • 96. ZAP-70 expression in CLL: a new parameter for an old disease.
    Bosch F; Villamor N
    Haematologica; 2003 Jul; 88(7):724-6. PubMed ID: 12857546
    [No Abstract]   [Full Text] [Related]  

  • 97. Unexpected interference in cell surface staining by monoclonal antibodies to unrelated antigens.
    De Vita M; Catzola V; Buzzonetti A; Fossati M; Battaglia A; Zamai L; Fattorossi A
    Cytometry B Clin Cytom; 2015; 88(5):352-4. PubMed ID: 25327621
    [TBL] [Abstract][Full Text] [Related]  

  • 98. ZAP-70 levels do change in CLL but not very often.
    Hamblin TJ
    Leuk Lymphoma; 2007 Jun; 48(6):1059-60. PubMed ID: 17577764
    [No Abstract]   [Full Text] [Related]  

  • 99. More ZAP for chronic lymphocytic leukemia (CLL).
    Wiestner A
    Blood; 2005 Mar; 105(5):1839-40. PubMed ID: 15747395
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Targeting chronic lymphocytic leukemia cells with a humanized monoclonal antibody specific for CD44.
    Zhang S; Wu CC; Fecteau JF; Cui B; Chen L; Zhang L; Wu R; Rassenti L; Lao F; Weigand S; Kipps TJ
    Proc Natl Acad Sci U S A; 2013 Apr; 110(15):6127-32. PubMed ID: 23530247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.